- Home
- CFBK vs LUCD Comparison
CFBK vs LUCD Comparison
Compare CFBK & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFBK | LUCD |
|---|---|---|
| Founded | 1892 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.4M | 190.8M |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CFBK | LUCD |
|---|---|---|
| Price | $27.80 | $1.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $29.00 | $3.94 |
| AVG Volume (30 Days) | 41.7K | ★ 562.8K |
| Earning Date | 05-05-2026 | 03-26-2026 |
| Dividend Yield | ★ 1.30% | N/A |
| EPS Growth | ★ 30.58 | 16.67 |
| EPS | ★ 2.69 | N/A |
| Revenue | N/A | ★ $4,346,000.00 |
| Revenue This Year | $32.28 | $149.41 |
| Revenue Next Year | N/A | $133.88 |
| P/E Ratio | $10.28 | ★ N/A |
| Revenue Growth | N/A | ★ 79.00 |
| 52 Week Low | $19.22 | $0.95 |
| 52 Week High | $34.34 | $1.80 |
Technical Indicators
Market Signals| Indicator | CFBK | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 34.67 |
| Support Level | $23.49 | $1.16 |
| Resistance Level | $29.95 | $1.22 |
| Average True Range (ATR) | 0.69 | 0.07 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 33.75 | 20.55 |
Price Performance
Historical ComparisonAbout CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.